Autopsy report · NCT00402948

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of substantial enrollment”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months before it started.
Ran for about 10 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Syntara
Sponsor type: Industry
Conditions: Asthma
Interventions: TPI ASM8; ASM8
Participants: 10
Sites: 10
Countries: Canada

Trials that died the same way

Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction
“Lack of enrollment” (93% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.